A third of young adults turn to artificial intelligence for substance-use information
Peer-Reviewed Publication
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 2-Nov-2026 21:15 ET (3-Nov-2026 02:15 GMT/UTC)
More than 32% of participants in a Rutgers study reported using ChatGPT and similar chatbots for substance-use information.
Researchers have developed BloomSight, an ultra-high-frequency, deep learning-powered framework for quantifying diurnal flowering dynamics in japonica and indica rice at minute-level resolution.
Punching a virtual response box or swinging a virtual lightsaber dramatically improved learning on certain tasks, revealing something fundamental about how people learn. New research challenges the long-held view that movement is simply a response to what the brain has already learned, suggesting instead that physical movement can actively shape learning. The findings could inform training in fields such as medicine and aviation, where integrating information and recognizing patterns are critical.
UC Cancer Center researchers, including lead author Wedad Alatebi, developed a deep learning survival model for breast cancer that combines detailed clinical and genetic information, potentially offering physicians a more accurate tool to guide treatment decisions.
October 26–27 | Dubai
Dr. Alex Aliper, Co-founder and President of Insilico Medicine, has been invited to attend the Dubai AI Festival 2026 at the Dubai World Trade Centre (DWTC).October 26–27 | Hong Kong
Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the 2026 Global Healthcare Innovation Summit (GHIS 2026) at the Grand Hyatt Hong Kong.October 28–30 | Seoul
Dr. Jue Wang Global Head of Business Development at Insilico Medicine, has been invited to attend BioPlus-Interphex Korea 2026 (BIX 2026) at COEX in Seoul.October 29 | Suzhou
Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the 6th SAPA-China 2026 Healthcare Industry Conference at the Suzhou Shishan International Conference Center.October 29–30 | Shenzhen
Dr. Alex Aliper, Co-founder and President of Insilico Medicine, has been invited to attend the 2026 Tencent Global Digital Ecosystem Summit, held in Hall 18 at the Shenzhen World Exhibition & Convention Center.